At the Wellcome Genome Campus we undertake genome and biodata research. We provide bioinformatics resources for the global scientific community and we deliver vital training in genomics and biodata to scientists and clinicians. We are at the interface of research and industry, translating science into tangible societal benefits.
As the developments around COVID-19 continue to evolve, we want you to know that the Wellcome Genome Campus is still closed for all but essential functions. To ensure continuity of operations, the majority of our staff are working remotely, making use of remote communication and collaboration tools. If you need to get in touch with us, please do so via email for a quick response. Please note that all events that were due to happen, including conferences and visits, are suspended until further notice. Dates for restarting various activities are being reviewed on an ongoing basis and we will update our websites and social media channels with any changes as soon as we can.
The Campus is home to two leading institutes as well as innovative genomics and biodata companies, scientific facilities, and a state of the art conference centre.
The Wellcome Sanger Institute is one of the premier hubs of genomic discovery and understanding in the world.
The main role of EMBL-EBI is to enable scientists to realise the potential of Big Data in biological sciences.
The BioData Innovation Centre is an incubator for genomics and biodata businesses of all sizes and at all stages of development.
Connecting Science's mission is to enable everyone to explore genomic science and its impact on research, health and society.
Genomics England’s sequencing centre is located here the Wellcome Genome Campus in the Bridget Ogilvie Building.
We expect our Campus community to grow significantly over the next 15 years. Find out more about the planning and the development work happening right now to make this a reality.Learn more
Our understanding of the human genome is opening up unexplored areas of diseases research in cancer, infectious diseases such as malaria and TB, and common inherited diseases that affect us all such as diabetes and arthritis. These new avenues of research will inform and drive the treatments of tomorrow, changing the way we are all diagnosed and treated in the future.
Professor Sir Mike Stratton Director, Wellcome Sanger Institute Chief Executive, Wellcome Genome Campus
Together, the Campus community works to ensure collaboration along the entire discovery pipeline - from initial idea through to new product, tool, technology, advice, or policy.Learn more
Our community is diverse and excellent; we have been at the forefront of genomics-based research and development since the early 1990s. Together, the Wellcome Sanger Institute and EMBL-EBI have pioneered an approach to open-access data sharing that is the foundation of future, accelerated scientific discovery.Learn more
The Campus is part of Wellcome, a global charitable foundation that exists to improve health for everyone by helping great ideas to thrive.Learn more